← The Wire
OKURNasdaq
OnKure Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1637715
Develops precision medicines targeting specific cancer mutations for improved efficacy and tolerability
red 8-K · 90d
$170M
Market cap
$4.50
Last close
0.0%
1D
+1.4%
5D
414K
Volume
Price · last 39 sessions-2.2%
May 4L $3.08 · H $4.60Jun 29
110
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
8-KExecutive Change · Shareholder VoteJun 4, 20268-KResults of OperationsMay 5, 202610-Q10-QMay 5, 2026DEFA14ADEFA14AApr 21, 2026DEF 14ADEF 14AApr 21, 2026SC 13DSC 13DApr 7, 20268-KExecutive Change · Material AgreementMar 30, 202610-K10-KMar 12, 20268-KResults of OperationsMar 12, 20268-KMaterial AgreementNov 6, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 202510-Q10-QAug 12, 20258-KResults of OperationsAug 12, 20258-KReg FD DisclosureJun 26, 20258-KShareholder VoteMay 28, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 16, 2025DEF 14ADEF 14AApr 16, 20258-KResults of OperationsMar 10, 202510-K10-KMar 10, 20258-KReg FD Disclosure · Company UpdateDec 10, 2024SC 13GONKURE THERAPEUTICS, INC.Nov 14, 20248-KAuditor Change · Company UpdateNov 7, 202410-Q10-QNov 7, 2024S-1S-1Oct 23, 2024SC 13GSC 13GOct 11, 2024SC 13GSC 13GOct 11, 2024SC 13GSC 13GOct 11, 2024SC 13GSC 13GOct 11, 2024SC 13GSC 13GOct 10, 2024SC 13GSC 13GOct 9, 20248-KChange of Control · Executive ChangeOct 8, 2024425425Oct 2, 20248-KShareholder VoteOct 2, 2024SC 13GSC 13GSep 26, 2024425425Sep 20, 20248-KCompany UpdateSep 20, 20248-KExecutive ChangeSep 13, 202410-Q10-QAug 13, 2024425425Aug 13, 20248-KResults of OperationsAug 13, 2024S-4S-4Jun 21, 2024425425May 13, 20248-KChange of Control · Executive ChangeMay 13, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 202410-K/A10-K/AApr 26, 202410-K10-KMar 28, 20248-KResults of OperationsMar 28, 20248-KExit / Disposal CostsFeb 23, 2024SC 13GSC 13GFeb 5, 2024SC 13GSC 13GJan 17, 2024SC 13DSC 13DDec 26, 20238-KExit / Disposal Costs · Company UpdateDec 14, 2023424B5424B5Nov 13, 202310-Q10-QNov 13, 20238-KResults of OperationsNov 13, 20238-KCompany UpdateOct 30, 20238-KReg FD Disclosure · Company UpdateOct 10, 202310-Q10-QAug 10, 20238-KResults of OperationsAug 10, 20238-KShareholder VoteJun 7, 202310-Q10-QMay 11, 20238-KResults of OperationsMay 11, 20238-KMaterial Agreement · Equity IssuanceMay 5, 2023424B5424B5May 4, 2023424B5424B5May 3, 20238-KResults of Operations · Reg FD DisclosureMay 3, 2023DEFA14ADEFA14AApr 26, 2023DEF 14ADEF 14AApr 26, 202310-K10-KMar 27, 20238-KResults of OperationsMar 27, 20238-KCompany UpdateMar 14, 20238-KReg FD DisclosureMar 10, 20238-KReg FD DisclosureJan 9, 202310-Q10-QNov 8, 20228-KResults of OperationsNov 8, 202210-Q10-QAug 9, 2022
Insider Activity
In the 90 days to Mar 23, 2026: 2 sold $2K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2026 | Leverone Jason A.Chief Financial Officer | Sell | 301 | $4.16 | $1K |
| Mar 23, 2026 | Saccomano Nicholas APresident and CEO | Sell | 86 | $4.16 | $358 |
| Dec 22, 2025 | Leverone Jason A.Chief Financial Officer | Sell | 302 | $2.97 | $897 |
| Dec 22, 2025 | Saccomano Nicholas APresident and CEO | Sell | 87 | $2.97 | $258 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance